Scarica l'app Stockscreener
5.12
4.70%
0.23
Dopo l'orario di chiusura:
5.10
-0.02
-0.39%
Precedente Chiudi:
$4.89
Aprire:
$4.74
Volume 24 ore:
107.69K
Relative Volume:
1.17
Capitalizzazione di mercato:
$60.30M
Reddito:
$200.00K
Utile/perdita netta:
$-26.17M
Rapporto P/E:
-1.9711
EPS:
-2.5976
Flusso di cassa netto:
$-18.63M
1 W Prestazione:
-5.01%
1M Prestazione:
-2.29%
6M Prestazione:
-36.08%
1 anno Prestazione:
+70.67%
Intervallo 1D:
$4.45
$5.21
Intervallo di 1 settimana:
$4.45
$5.48
Portata 52W:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.12 | 60.30M | 200.00K | -26.17M | -18.63M | -2.5976 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Top Nanotechnology Stocks To Follow NowApril 5th - MarketBeat
Best Nanotechnology Stocks To Keep An Eye OnApril 4th - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Sells $21,261.66 in Stock - MarketBeat
Clene Inc. ten percent owner sells $21k in stock By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $21k in stock - investing.com
Clene (CLNN) 10% holder’s LLC sells 4,278 shares, keeps 426,816 - Stock Titan
Promising Nanotechnology Stocks To ResearchApril 1st - MarketBeat
Clene Inc. (CLNN) ten percent owner sells $494k in stock - Investing.com Canada
Symbiosis II sells multiple CLNN shares (NASDAQ: CLNN) in early 2026 - Stock Titan
Entity linked to Clene (CLNN) sells 100,997 common shares - Stock Titan
Sentiment Review: Is Clene Inc a play on infrastructure spending2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 29th - MarketBeat
EPS Watch: What hedge funds are buying Clene Inc Equity WarrantMarket Volume Summary & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Top Nanotechnology Stocks To Keep An Eye OnMarch 28th - MarketBeat
Market Outlook: Should I buy Clene Inc Equity Warrant stock now2026 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Nanotechnology Stocks To ResearchMarch 27th - MarketBeat
Clene Inc. ten percent owner sells $99k in shares By Investing.com - Investing.com India
Aug Catalysts: Is Clene Inc a top pick in the sectorTrade Risk Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Clene Inc. ten percent owner sells $99k in shares - Investing.com
Clene (CLNN) holder SymBiosis II sells 17,909 common shares - Stock Titan
Nanotechnology Stocks Worth WatchingMarch 26th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistMarch 25th - MarketBeat
Risk Analysis: Can Clene Inc reach resistance levels soon2026 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Aug Big Picture: Will Clene Inc benefit from AI trendsGlobal Markets & Growth Focused Entry Reports - baoquankhu1.vn
Symbiosis II LLC plans resale of CLNN (NASDAQ: CLNN) — 477,000 shares - Stock Titan
CLNN Stock Price, Quote & Chart | CLENE INC (NASDAQ:CLNN) - ChartMill
Nanotechnology Stocks To ConsiderMarch 22nd - MarketBeat
If You Invested $1,000 in Clene (CLNN) - Stock Titan
Top Nanotechnology Stocks To ConsiderMarch 21st - MarketBeat
Whale Trades: Will Clene Inc Equity Warrant outperform during market rallies2026 Key Lessons & Fast Momentum Entry Tips - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Hengan International Group Co (OtherHEGIF) and Clene (CLNN) - The Globe and Mail
Highs Report: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAR - baoquankhu1.vn
Clene Secures Third-Year NIH Subaward for ALS Program - The Globe and Mail
Clene Inc. Announces NIH Subaward Agreement for ALS Expanded Access Protocol – SEC Filing Details - Minichart
Treasury Yields: Is Clene Inc Equity Warrant stock undervalued right nowPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayMarch 17th - MarketBeat
Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook - Minichart
Clene 10-K: Revenue $0.2M, EPS $(2.65) — Net Loss $(26.17)M - TradingView
Clene (NASDAQ: CLNN) pushes CNM-Au8 toward accelerated ALS approval - Stock Titan
Clene Inc. (NASDAQ: CLNN) secures $8M Year 3 ALS grant funding - Stock Titan
Clene (CLNN) Projected to Post Earnings on Monday - MarketBeat
Q1 Earnings Estimate for Clene Issued By HC Wainwright - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 15th - MarketBeat
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and American Public Education (APEI) - The Globe and Mail
Clene Inc. (NASDAQ:CLNN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
Clene (NASDAQ:CLNN) Receives Buy Rating from Canaccord Genuity Group - MarketBeat
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
Clene (NASDAQ:CLNN) Issues Earnings Results - MarketBeat
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):